• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致死性紧张症与抗精神病药恶性综合征。一种多巴胺受体关闭假说。

Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis.

作者信息

Osman A A, Khurasani M H

机构信息

King Fahd Hospital, Jeddah, Saudi Arabia.

出版信息

Br J Psychiatry. 1994 Oct;165(4):548-50. doi: 10.1192/bjp.165.4.548.

DOI:10.1192/bjp.165.4.548
PMID:7804674
Abstract

BACKGROUND

Lethal catatonia and neuroleptic malignant syndrome (NMS) have been suggested to have a common neurochemical cause. We hypothesise that both conditions may be due to a sudden and massive blockade of dopamine neurotransmitters.

METHOD

NMS was diagnosed in psychotic in-patients treated with neuroleptics if four features were present: diffuse severe rigidity, altered level of consciousness, hyperpyrexia and autonomic instability.

RESULTS

Over three years, five NMS cases were diagnosed. Two presented with catatonic features and were diagnosed as acute reactive psychosis. Their neuroleptic doses were small, arguing for a particular sensitivity in these two cases.

CONCLUSION

The sensitivity of two patients with catatonic features who developed NMS with small doses of neuroleptics supports a common neurochemical basis for the two conditions.

摘要

背景

致死性紧张症和抗精神病药恶性综合征(NMS)被认为有共同的神经化学病因。我们推测这两种情况可能是由于多巴胺神经递质的突然大量阻断所致。

方法

如果精神病住院患者出现以下四个特征,则诊断为NMS:弥漫性严重僵硬、意识水平改变、高热和自主神经功能不稳定。

结果

在三年多的时间里,共诊断出5例NMS病例。其中2例表现出紧张症特征,被诊断为急性反应性精神病。他们使用的抗精神病药剂量较小,说明这两例具有特殊敏感性。

结论

两名具有紧张症特征的患者在使用小剂量抗精神病药后发生NMS,这支持了这两种情况有共同神经化学基础的观点。

相似文献

1
Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis.致死性紧张症与抗精神病药恶性综合征。一种多巴胺受体关闭假说。
Br J Psychiatry. 1994 Oct;165(4):548-50. doi: 10.1192/bjp.165.4.548.
2
[Acute catatonic syndrome after neuroleptic malignant syndrome].[抗精神病药恶性综合征后的急性紧张症综合征]
Encephale. 2005 Nov-Dec;31(6 Pt 1):705-9. doi: 10.1016/s0013-7006(05)82429-7.
3
Neuroleptic catatonia and its relationship to psychogenic catatonia.抗精神病药所致紧张症及其与心因性紧张症的关系。
Biol Psychiatry. 1985 Mar;20(3):304-13. doi: 10.1016/0006-3223(85)90060-5.
4
Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.紧张症变体、高热性锥体外系反应及抗精神病药恶性综合征的亚型
Ann Clin Psychiatry. 2007 Jan-Mar;19(1):9-16. doi: 10.1080/10401230601163477.
5
Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.在自主神经症状出现之前出现的紧张症症状有助于将抗精神病药恶性综合征与恶性紧张症区分开来。
Intern Med. 2016;55(19):2893-2897. doi: 10.2169/internalmedicine.55.6613. Epub 2016 Oct 1.
6
Neuroleptic malignant syndrome.
Br J Psychiatry. 1995 Apr;166(4):537-8. doi: 10.1192/bjp.166.4.537.
7
The neuroleptic malignant syndrome--a review.抗精神病药恶性综合征——综述
Q J Med. 1985 Aug;56(220):421-9.
8
Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.紧张症作为抗精神病药恶性综合征发生的一个危险因素:1例氯氮平治疗后病例报告
World J Biol Psychiatry. 2009;10(1):70-3. doi: 10.1080/15622970701287369.
9
[Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].[紧张症与抗精神病药恶性综合征:两种处于同一谱系的疾病?三例报告]
Riv Psichiatr. 2012 Mar-Apr;47(2):178-85. doi: 10.1708/1069.11721.
10
Catatonia and neuroleptic malignant syndrome: two sides of a coin?紧张症与抗精神病药恶性综合征:同一硬币的两面?
Acta Neurol Belg. 2007 Jun;107(2):47-50.

引用本文的文献

1
Three Episodes of Neuroleptic Malignant Syndrome With Risperidone: A Case Report and Literature Review.三例使用利培酮引发的抗精神病药恶性综合征:病例报告及文献综述
Case Rep Psychiatry. 2025 Sep 11;2025:6669246. doi: 10.1155/crps/6669246. eCollection 2025.
2
Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report.电休克治疗用于快速控制抗精神病药恶性综合征症状:一例报告
Front Psychiatry. 2023 Mar 23;14:1143407. doi: 10.3389/fpsyt.2023.1143407. eCollection 2023.
3
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
抗精神病药治疗伴有紧张症症状的精神分裂症谱系障碍。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD013100. doi: 10.1002/14651858.CD013100.pub2.
4
Lorazepam-Resistant Catatonia in an Antipsychotic-Naïve 24-Year-Old with Psychotic Symptoms.一名24岁未使用过抗精神病药物且有精神病症状的患者出现对劳拉西泮耐药的紧张症
Case Rep Psychiatry. 2020 Apr 3;2020:2469707. doi: 10.1155/2020/2469707. eCollection 2020.
5
Treatable Neuropsychiatric Syndrome of Catatonia: A Case Review from Oman.可治疗的紧张症性神经精神综合征:阿曼的病例回顾
Oman Med J. 2013 Sep;28(5):e056. doi: 10.5001/omj.2013.108.
6
Diagnostic, Treatment, and System Challenges in the Management of Recurrent Neuroleptic Malignant Syndrome on a General Medical Service.综合内科服务中复发性抗精神病药恶性综合征管理的诊断、治疗及系统挑战
Case Rep Psychiatry. 2018 Jun 11;2018:4016087. doi: 10.1155/2018/4016087. eCollection 2018.
7
Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.苯二氮䓬类药物的反应及与精神分裂症相关的恶性紧张症的临床病程:一例报告
Medicine (Baltimore). 2017 Apr;96(16):e6566. doi: 10.1097/MD.0000000000006566.
8
Systemic Lupus Erythematous Presenting as Catatonia and its Response to Electroconvulie Therapy.以紧张症为表现的系统性红斑狼疮及其对电惊厥治疗的反应
Indian J Psychol Med. 2015 Oct-Dec;37(4):456-9. doi: 10.4103/0253-7176.168597.
9
Catatonia in patients with autism: prevalence and management.自闭症患者的紧张症:患病率和管理。
CNS Drugs. 2014 Mar;28(3):205-15. doi: 10.1007/s40263-014-0143-9.
10
Clozapine responsive catatonia: A series of five cases.氯氮平反应性紧张症:五例系列报道。
Ind Psychiatry J. 2012 Jan;21(1):66-8. doi: 10.4103/0972-6748.110955.